AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6400534 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefsulodin alone (31 patients)
Number of subjects: 40
Study 6400534 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefsulodin in combination with a nonantipseudomonal antibiotic (9 patients)
Number of subjects: 40
Study 6400534 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefsulodin (2-8 g/day) for 4-37 days (25 patients)
Number of subjects: 40
Study 6400534 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefsulodin (4-12 g/day) for 5-45 days (15 patients)
Number of subjects: 40
Study 30767663 — intervention group
Group type: EXPERIMENTAL
Intervention: BioFreedom biolimus‐eluting stents (BES)
Number of subjects: 1280
Study 30767663 — intervention group
Group type: COMPARATOR
Intervention: Cre8 amphilimus‐eluting stents (AES)
Number of subjects: 1280
Study 29063703 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab (0.5 mg)
Number of subjects: 25
Study 29063703 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone (8 mg)
Number of subjects: 25
Study 27289365 — intervention group
Group type: EXPERIMENTAL
Intervention: TFMPP (60 mg)
Number of subjects: 82
Study 27289365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 27289365 — intervention group
Group type: EXPERIMENTAL
Intervention: BZP (200 mg)
Number of subjects: 82
Study 27289365 — intervention group
Group type: EXPERIMENTAL
Intervention: BZP + TFMPP (100 mg/30 mg)
Number of subjects: 82
Study 27289365 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamphetamine (20 mg)
Number of subjects: 82
Study 27289365 — intervention group
Group type: EXPERIMENTAL
Intervention: All drug treatments
Number of subjects: 82
Study 25483691 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervarix®
Number of subjects: 0
Study 25483691 — intervention group
Group type: COMPARATOR
Intervention: Gardasil®
Number of subjects: 0
Study 25483691 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervarix® and Gardasil®
Number of subjects: 0
Study 23134924 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydration therapy (2 liters of water within 2 hours, then 2 liters daily for 7 days)
Number of subjects: 64
Study 23134924 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydration therapy
Number of subjects: 64
Study 23134924 — intervention group
Group type: COMPARATOR
Intervention: Routine water intake (control group)
Number of subjects: 64
Study 20533037 — intervention group
Group type: EXPERIMENTAL
Intervention: +BOPT
Number of subjects: 36
Study 18957869 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-animal-protein diet (LAPD)
Number of subjects: 175
Study 18957869 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber diet (HFD)
Number of subjects: 175
Study 18957869 — intervention group
Group type: COMPARATOR
Intervention: Normal diet (control group)
Number of subjects: 175
Study 18957869 — intervention group
Group type: EXPERIMENTAL
Intervention: LAPD
Number of subjects: 175
Study 18957869 — intervention group
Group type: EXPERIMENTAL
Intervention: HFD
Number of subjects: 175
Study 16319109 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3 mg i.v. bolus 30 min before cisplatin on Day 1 and a 0.1 mg tablet for Days 2 to 5)
Number of subjects: 73
Study 16319109 — intervention group
Group type: COMPARATOR
Intervention: Granisetron (3 mg i.v. infusion 30 min before cisplatin on Day 1 and a 1 mg tablet for Days 2 to 5)
Number of subjects: 73
Study 12830468 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of 300 mg ascorbic acid
Number of subjects: 35
Study 12830468 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ascorbic acid)
Number of subjects: 35
Study 10792412 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS stimulation applied for 15 min over the sural nerve in the left leg
Number of subjects: 50
Study 10792412 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TENS stimulation)
Number of subjects: 50
Study 8105737 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 40
Study 8105737 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 8105737 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical bone mineral density
Number of subjects: 40
Study 3628857 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoglutethimide 1000 mg and hydrocortisone 40 mg daily
Number of subjects: 50
Study 3628857 — intervention group
Group type: COMPARATOR
Intervention: Aminoglutethimide 1000 mg, hydrocortisone 40 mg and fluoxymesterone 20 mg daily
Number of subjects: 50
Study 29605123 — intervention group
Group type: EXPERIMENTAL
Intervention: Training of radiographers in RSA imaging technique
Number of subjects: 0
Study 27423556 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel and aspirin (dual therapy)
Number of subjects: 100
Study 27423556 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (monotherapy)
Number of subjects: 100
Study 25995278 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B-12 intake of ∼8.6 μg/d (mixed diet plus prenatal multivitamin supplement)
Number of subjects: 75
Study 23809021 — intervention group
Group type: COMPARATOR
Intervention: Supreme Laryngeal Mask Airway (S‐LMA)
Number of subjects: 60
Study 23809021 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSeal Laryngeal Mask Airway (P‐LMA)
Number of subjects: 60
Study 21508941 — intervention group
Group type: EXPERIMENTAL
Intervention: screening with STOPP/START criteria followed up with recommendations to attending physicians
Number of subjects: 400
Study 21508941 — intervention group
Group type: COMPARATOR
Intervention: usual pharmaceutical care (control)
Number of subjects: 400
Study 19390971 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU) intervention
Number of subjects: 100
Study 19390971 — intervention group
Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 100
Study 16919533 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 37
Study 16919533 — intervention group
Group type: COMPARATOR
Intervention: Nisoldipine
Number of subjects: 37
Study 16919533 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of telmisartan and nisoldipine
Number of subjects: 37
Study 15598112 — intervention group
Group type: EXPERIMENTAL
Intervention: Activating abstract concepts (i.e., crime and basketball)
Number of subjects: 0
Study 15598112 — intervention group
Group type: EXPERIMENTAL
Intervention: Black faces
Number of subjects: 0
Study 15598112 — intervention group
Group type: EXPERIMENTAL
Intervention: Social group member representation
Number of subjects: 0
Study 11277275 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (1,25‐dihydroxyvitamin D3; 0.5 microg/day) for 6 months
Number of subjects: 41
Study 11277275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclical etidronate plus calcium for 6 months
Number of subjects: 41
Study 11277275 — intervention group
Group type: COMPARATOR
Intervention: Untreated reference group
Number of subjects: 41
Study 10442545 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (beclomethasone dipropionate nasal spray, betamethasone nasal drops)
Number of subjects: 0
Study 10442545 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide and budesonide
Number of subjects: 0
Study 10442545 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (long-term therapy)
Number of subjects: 0
Study 8085929 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation during continuous passive motion (CPM) treatment
Number of subjects: 40
Study 8085929 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (control group)
Number of subjects: 40
Study 2670693 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant interferon alpha 2A (Roferon‐A) at a dosage of 10 million units (MU)/m2 thrice weekly for six months
Number of subjects: 45
Study 2670693 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower doses of interferon (5 MU/m2 and 2.5 MU/m2)
Number of subjects: 45
Study 2670693 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 45
Study 1066825 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised daily dental and oral care
Number of subjects: 149
Study 31984760 — intervention group
Group type: EXPERIMENTAL
Intervention: URF‐Y0016
Number of subjects: 25
Study 31984760 — intervention group
Group type: COMPARATOR
Intervention: URF‐P6
Number of subjects: 25
Study 31302340 — intervention group
Group type: COMPARATOR
Intervention: Pidotimod alone
Number of subjects: 100
Study 31302340 — intervention group
Group type: COMPARATOR
Intervention: Pidotimod plus bifidobacteria
Number of subjects: 100
Study 31302340 — intervention group
Group type: COMPARATOR
Intervention: Bifidobacteria alone
Number of subjects: 100
Study 31302340 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 100
Study 27898207 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya yoga (SKY)
Number of subjects: 25
Study 27898207 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 25
Study 26066789 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylureas (SUs)
Number of subjects: 59
Study 23525044 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (L-DOPA)
Number of subjects: 0
Study 23525044 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 21348963 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held dynamic contour tonometer (HH-DCT)
Number of subjects: 92
Study 21348963 — intervention group
Group type: COMPARATOR
Intervention: Perkins applanation tonometer (PAT)
Number of subjects: 92
Study 21348963 — intervention group
Group type: COMPARATOR
Intervention: TonoPenXL (TPXL)
Number of subjects: 92
Study 21348963 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of IOP range between devices
Number of subjects: 92
Study 19481750 — intervention group
Group type: EXPERIMENTAL
Intervention: Kegel exercises
Number of subjects: 240
Study 19481750 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 240
Study 16562586 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents with DM2
Number of subjects: 57
Study 12972745 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 4465
Study 12972745 — intervention group
Group type: COMPARATOR
Intervention: Intravenous meperidine analgesia
Number of subjects: 4465
Study 11193131 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE 0.3 mg
Number of subjects: 14
Study 11193131 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg
Number of subjects: 14
Study 11193131 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE 1.25 mg
Number of subjects: 14
Study 11193131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 9590932 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal splint therapy with a positioning orifice
Number of subjects: 0
Study 8290457 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine solution undiluted
Number of subjects: 6
Study 8290457 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine solution 1:10
Number of subjects: 6
Study 8290457 — intervention group
Group type: EXPERIMENTAL
Intervention: Octenidine 0.1%
Number of subjects: 6
Study 8290457 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.1%
Number of subjects: 6
Study 8290457 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexetidine 0.1%
Number of subjects: 6
Study 8290457 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.05%
Number of subjects: 6
Study 8290457 — intervention group
Group type: EXPERIMENTAL
Intervention: All procedures except chlorhexidine 0.05% after 30 minutes
Number of subjects: 6
Study 3522510 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 60
Study 30043979 — intervention group
Group type: EXPERIMENTAL
Intervention: Lozenges containing specific IgY against P. gingivalis gingipains
Number of subjects: 64
Study 30043979 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenges (sham-immune IgY)
Number of subjects: 64
Study 30043979 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (test and placebo)
Number of subjects: 64
Study 27311914 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-guidance of anaesthetic agent administration
Number of subjects: 1232
Study 27311914 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia with clinicians blinded to EEG monitoring
Number of subjects: 1232
Study 24516192 — intervention group
Group type: EXPERIMENTAL
Intervention: Upstream clopidogrel treatment prior to catheterisation laboratory arrival
Number of subjects: 423
Study 24516192 — intervention group
Group type: COMPARATOR
Intervention: No upstream clopidogrel treatment
Number of subjects: 423
Study 23210197 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) gel
Number of subjects: 120
Study 23210197 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (MTZ) gel
Number of subjects: 120
Study 23210197 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-Metronidazole (CHX-MTZ) gel
Number of subjects: 120
Study 23210197 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 120
Study 20208382 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised cardiac rehabilitation (CR) for 6 months
Number of subjects: 111
Study 19099126 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone 2 mg/kg/day
Number of subjects: 21
Study 19099126 — intervention group
Group type: COMPARATOR
Intervention: Prednisone 1 mg/kg/day
Number of subjects: 21
Study 19099126 — intervention group
Group type: COMPARATOR
Intervention: Prednisone tapering to 0.5 mg/kg/day or less in one month
Number of subjects: 21
Study 16026380 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone monotherapy
Number of subjects: 0
Study 16026380 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin monotherapy
Number of subjects: 0
Study 16026380 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone + sulphonylurea
Number of subjects: 0
Study 16026380 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin + sulphonylurea
Number of subjects: 0
Study 12032792 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory, tactile, visual, and vestibular (ATVV) intervention
Number of subjects: 117
Study 12032792 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonexposed and drug-exposed)
Number of subjects: 117
Study 12032792 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (nonexposed and drug-exposed)
Number of subjects: 117
Study 12032792 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonexposed)
Number of subjects: 117
Study 12032792 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (nonexposed)
Number of subjects: 117
Study 12032792 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (drug-exposed)
Number of subjects: 117
Study 12032792 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined drug-specific groups (control+experimental)
Number of subjects: 117
Study 12032792 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (cocaine-exposed)
Number of subjects: 117
Study 10485539 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 20 microg/kg
Number of subjects: 120
Study 10485539 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 40 microg/kg
Number of subjects: 120
Study 10485539 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 80 microg/kg
Number of subjects: 120
Study 10485539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 8914038 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. iron dextran 5 ml every 2 weeks
Number of subjects: 37
Study 8914038 — intervention group
Group type: COMPARATOR
Intervention: oral ferrous sulphate 200 mg tds
Number of subjects: 37
Study 8914038 — intervention group
Group type: COMPARATOR
Intervention: no iron
Number of subjects: 37
Study 1878232 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular piritramide (7.5 to 15 mg as needed)
Number of subjects: 60
Study 1878232 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous PCA with fentanyl (demand dose 34 micrograms)
Number of subjects: 60
Study 1878232 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous PCA with buprenorphine (demand dose 80 micrograms)
Number of subjects: 60
Study 6751238 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral theophylline and salbutamol combination
Number of subjects: 0
Study 6751238 — intervention group
Group type: COMPARATOR
Intervention: Oral theophylline alone
Number of subjects: 0
Study 31519683 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (surgery with suture anchors)
Number of subjects: 60
Study 31519683 — intervention group
Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 60
Study 27862660 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus body and movement-oriented intervention
Number of subjects: 70
Study 27862660 — intervention group
Group type: COMPARATOR
Intervention: TAU only
Number of subjects: 70
Study 25275701 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS‐TBNA
Number of subjects: 110
Study 25275701 — intervention group
Group type: COMPARATOR
Intervention: EUS‐FNA
Number of subjects: 110
Study 24739996 — intervention group
Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 14
Study 24739996 — intervention group
Group type: COMPARATOR
Intervention: Airtraq laryngoscope
Number of subjects: 14
Study 21138358 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac adhesive film (30 mg) applied over the surgical site immediately after surgery.
Number of subjects: 68
Study 21138358 — intervention group
Group type: COMPARATOR
Intervention: Control group received adhesive film without KT initially, followed by KT adhesive film applied after 2 hours.
Number of subjects: 68
Study 19691426 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg once daily
Number of subjects: 103
Study 19691426 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 200 mg once daily
Number of subjects: 103
Study 17847764 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRHa) continuously administered for 12 days after embryo transfer
Number of subjects: 181
Study 17847764 — intervention group
Group type: COMPARATOR
Intervention: GnRH agonist (GnRHa) stopped on the day of human chorionic gonadotropin administration
Number of subjects: 181
Study 17147756 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls prevention strategies not involving behaviour change
Number of subjects: 24
Study 17147756 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial falls prevention packages
Number of subjects: 24
Study 17147756 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation with individual potential participants
Number of subjects: 24
Study 17147756 — intervention group
Group type: EXPERIMENTAL
Intervention: Expensive falls prevention programs
Number of subjects: 24
Study 11746330 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment A (specific treatment not mentioned)
Number of subjects: 0
Study 11746330 — intervention group
Group type: COMPARATOR
Intervention: Treatment B (specific treatment not mentioned)
Number of subjects: 0
Study 9052899 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium intake (20 mmol NaCl/d)
Number of subjects: 0
Study 9052899 — intervention group
Group type: COMPARATOR
Intervention: Regular sodium intake (210 mmol NaCl/d)
Number of subjects: 0
Study 8238214 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone oil
Number of subjects: 404
Study 8238214 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting gas
Number of subjects: 404
Study 8238214 — intervention group
Group type: COMPARATOR
Intervention: No retinotomy
Number of subjects: 404
Study 2962878 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopaminergic agonist co-dergocrine
Number of subjects: 0
Study 2962878 — intervention group
Group type: COMPARATOR
Intervention: Selective D-2 dopamine receptor blocker sulpiride
Number of subjects: 0
Study 31117218 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g lactitol
Number of subjects: 172
Study 31117218 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5 g psyllium
Number of subjects: 172
Study 31117218 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 10 g lactitol and 3.5 g psyllium
Number of subjects: 172
Study 31117218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study 29879268 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 80
Study 29879268 — intervention group
Group type: COMPARATOR
Intervention: Saline alone (Control)
Number of subjects: 80
Study 27769826 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-containing mouthwash
Number of subjects: 17
Study 27769826 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 17
Study 24114746 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Training Technique (ATT)
Number of subjects: 0
Study 24114746 — intervention group
Group type: COMPARATOR
Intervention: Control group (filler task)
Number of subjects: 0
Study 23137493 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartNet (Paracor Medical) plus optimal heart failure drug and device therapy
Number of subjects: 272
Study 23137493 — intervention group
Group type: COMPARATOR
Intervention: Optimal drug and device therapy alone
Number of subjects: 272
Study 20140826 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency miniprobes (HFPs)
Number of subjects: 43
Study 20140826 — intervention group
Group type: COMPARATOR
Intervention: Conventional radial endoscopic ultrasonography (crEUS)
Number of subjects: 43
Study 18706826 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside Entertainment Services (BES)
Number of subjects: 100
Study 18706826 — intervention group
Group type: COMPARATOR
Intervention: No Bedside Entertainment Services (Control)
Number of subjects: 100
Study 15729158 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental cues (locations, role relationships, network ties, first letters of names)
Number of subjects: 123
Study 15729158 — intervention group
Group type: EXPERIMENTAL
Intervention: First-name cues
Number of subjects: 123
Study 15729158 — intervention group
Group type: COMPARATOR
Intervention: Individual characteristics cues
Number of subjects: 123